Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3613)
Ascendis Pharma A/S (ASND)
JENSEN FLEMMING STEEN — EVP & Product Supply and Quality
Shares
19,460
Price
$238.49
Total Value
$4.64M
Shares Held After
0
% of Holdings
100.0%
Arcus Biosciences, Inc. (RCUS)
Goeltz II Robert C. — Chief Financial Officer
Shares
7,763
Price
$25.63
Total Value
$198.97K
Shares Held After
84,161
% of Holdings
8.4%
FENNEC PHARMACEUTICALS INC. (FENC)
RALLIS CHRIS A — Director
Shares
8,346
Price
$7.04
Total Value
$58.76K
Shares Held After
63,077
% of Holdings
11.7%
Caris Life Sciences, Inc. (CAI)
Vacirca Jeff L — Director
Shares
31,050
Price
$16.15
Total Value
$501.43K
Shares Held After
49,671
% of Holdings
62.5%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
5,808
Price
$30.56
Total Value
$177.49K
Shares Held After
162,331
% of Holdings
3.5%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
6,979
Price
$30.04
Total Value
$209.65K
Shares Held After
168,139
% of Holdings
4.0%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
846
Price
$28.70
Total Value
$24.28K
Shares Held After
175,118
% of Holdings
0.5%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
284
Price
$27.61
Total Value
$7.84K
Shares Held After
175,964
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
5,890
Price
$30.56
Total Value
$180.00K
Shares Held After
1,512,329
% of Holdings
0.4%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
6,871
Price
$30.04
Total Value
$206.40K
Shares Held After
1,518,219
% of Holdings
0.5%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
877
Price
$28.70
Total Value
$25.17K
Shares Held After
1,525,090
% of Holdings
0.1%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
342
Price
$27.57
Total Value
$9.43K
Shares Held After
1,525,967
% of Holdings
0.0%
ABEONA THERAPEUTICS INC. (ABEO)
Vasanthavada Madhav — Chief Commercial Officer
Shares
5,548
Price
$5.96
Total Value
$33.07K
Shares Held After
313,071
% of Holdings
1.7%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
184,639
Price
$46.22
Total Value
$8.53M
Shares Held After
2,671,822
% of Holdings
6.5%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
184,639
Price
$46.22
Total Value
$8.53M
Shares Held After
2,671,822
% of Holdings
6.5%
Kymera Therapeutics, Inc. (KYMR)
Ridloff Elena — Director
Shares
3,000
Price
$87.00
Total Value
$261.00K
Shares Held After
0
% of Holdings
100.0%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
305,741
Price
$0.70
Total Value
$214.02K
Shares Held After
1,273,008
% of Holdings
19.4%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$42.14
Total Value
$1.05M
Shares Held After
1,323,095
% of Holdings
1.9%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
25,012
Price
$0.71
Total Value
$17.76K
Shares Held After
418,813
% of Holdings
5.6%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
351,514
Price
$0.71
Total Value
$249.57K
Shares Held After
5,885,968
% of Holdings
5.6%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
600
Price
$79.28
Total Value
$47.57K
Shares Held After
105,212
% of Holdings
0.6%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
200
Price
$78.00
Total Value
$15.60K
Shares Held After
105,812
% of Holdings
0.2%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,900
Price
$79.31
Total Value
$150.69K
Shares Held After
105,212
% of Holdings
1.8%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
840
Price
$78.23
Total Value
$65.71K
Shares Held After
107,112
% of Holdings
0.8%
uniQure N.V. (QURE)
Abi-Saab Walid — Chief Medical Officer
Shares
20,000
Price
$25.00
Total Value
$500.00K
Shares Held After
169,669
% of Holdings
10.5%
uniQure N.V. (QURE)
Abi-Saab Walid — Chief Medical Officer
Shares
25,000
Price
$25.10
Total Value
$627.50K
Shares Held After
189,669
% of Holdings
11.6%
BIO-TECHNE Corp (TECH)
Herr Amy E. — Director
Shares
6,636
Price
$48.28
Total Value
$320.39K
Shares Held After
200
% of Holdings
97.1%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
3,205
Price
$29.20
Total Value
$93.59K
Shares Held After
1,526,309
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
1,582
Price
$28.56
Total Value
$45.18K
Shares Held After
1,529,514
% of Holdings
0.1%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
29,624
Price
$27.48
Total Value
$814.07K
Shares Held After
1,531,096
% of Holdings
1.9%
Protagonist Therapeutics, Inc (PTGX)
Giraudo Bryan — Director
Shares
5,130
Price
$100.00
Total Value
$513.00K
Shares Held After
12,695
% of Holdings
28.8%
Protagonist Therapeutics, Inc (PTGX)
Giraudo Bryan — Director
Shares
6,000
Price
$100.00
Total Value
$600.00K
Shares Held After
0
% of Holdings
100.0%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
59,767
Price
$44.58
Total Value
$2.66M
Shares Held After
2,856,461
% of Holdings
2.0%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
59,767
Price
$44.58
Total Value
$2.66M
Shares Held After
2,856,461
% of Holdings
2.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
950
Price
$68.35
Total Value
$64.93K
Shares Held After
4,358,447
% of Holdings
0.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,076
Price
$67.35
Total Value
$341.85K
Shares Held After
4,359,397
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
13,974
Price
$66.65
Total Value
$931.37K
Shares Held After
4,364,473
% of Holdings
0.3%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
950
Price
$68.35
Total Value
$64.93K
Shares Held After
555,686
% of Holdings
0.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,077
Price
$67.35
Total Value
$341.91K
Shares Held After
556,636
% of Holdings
0.9%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
13,973
Price
$66.65
Total Value
$931.31K
Shares Held After
561,713
% of Holdings
2.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Soteropoulos Paula — Director
Shares
599
Price
$85.47
Total Value
$51.20K
Shares Held After
0
% of Holdings
100.0%
Rapport Therapeutics, Inc. (RAPP)
Third Rock Ventures V, L.P. — 10% Owner
Shares
5,018
Price
$40.31
Total Value
$202.26K
Shares Held After
6,432,715
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$571.66
Total Value
$297.27K
Shares Held After
40,513
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
495
Price
$570.22
Total Value
$282.26K
Shares Held After
41,033
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
106
Price
$569.61
Total Value
$60.38K
Shares Held After
41,528
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$568.16
Total Value
$204.54K
Shares Held After
41,634
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
319
Price
$567.21
Total Value
$180.94K
Shares Held After
41,994
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
705
Price
$565.99
Total Value
$399.02K
Shares Held After
42,313
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,983
Price
$564.77
Total Value
$1.12M
Shares Held After
43,018
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,864
Price
$564.00
Total Value
$1.05M
Shares Held After
45,001
% of Holdings
4.0%
Showing 1051–1100 of 3613 transactions (page 22 of 73)